Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Hosted on MSN2h
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already ...
labiotech3h
Five biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates
Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...
GlobalData on MSN3d
Obesity trial surge puts the focus back on decentralisation
As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.
Weight-loss drugs: How much should investors worry about side effects?
Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...
Boise State Public Radio5d
In Good Health: The obesity rate is falling. What do weight loss drugs have to do with it?
As part of our series In Good Health, we discuss these new medications and the falling rate of obesity.
Mounjaro will soon be available as a weight loss treatment on the NHS. Here's what that means for patients
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...
GEN6d
StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
Investors appear enthused by BioAge’s focus on the red-hot obesity drug space, where both Novo Nordisk and Eli ... in two Phase II trials designed to assess the oral apelin receptor (APJ) agonist’s ...
thedailyupside6d
Obesity Drugmaker Rivus Wants in on the Healthcare IPO Boom
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Health.com6d
Study: Ozempic May Improve This Chronic Skin Condition
A new study shows semaglutide medications, such as Ozempic and Wegovy, may be effective in treating hidradenitis suppurativa ...